Track Elevance Health Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Elevance Health Inc. Common Stock ELV · Stock Open Elevance Health Inc. Common Stock in new tab

429.69 USD
P/E
18.24
EPS
23.55
Yield
1.61%
Safety Score
100
P/B
2.08
ROE
11.48
Beta
0.63
Target Price
482.38 USD
Elevance Health Inc. Common Stock logo

Elevance Health Inc. Common Stock

🧾 Earnings Recap – Q3 2026

Elevance raised its 2026 adjusted EPS outlook and set a higher earnings baseline, while projecting at least 12% EPS growth in 2027. Shares fell 1.4%, a broadly flat reaction that tempers the upbeat outlook; the transcript does not identify a specific source of investor disappointment.

  • 2026 adjusted diluted EPS guidance was raised to at least $29; the company also raised its underlying earnings baseline to at least $26.75, citing better operating results and favorable non-operating items.
  • Management expects at least 12% adjusted EPS growth in 2027, driven by Health Benefits margin improvement, Carelon adoption, and operating efficiency.
  • Medicaid results were ahead of outlook, primarily due to recent rate actions, and the business is tracking slightly ahead of its prior full-year margin guidance.
  • About half of Medicare Advantage members will be in plans rated 4 stars or higher for 2027; management said its plan design and market focus support further margin improvement.
  • Carelon’s commercial cancer care engagement program reduced avoidable inpatient admissions by 15%; its Elevate platform identified more than $300 million in anticipated savings this year.
📅
Loading chart...
Key Metrics
Earnings dateJan. 27, 2027
P/E18.24
EPS23.55
Book Value206.75
Price to Book2.08
Debt/Equity68.66
% Insiders0.186%
Growth
Revenue Growth0.01%
Earnings Growth0.18%
Estimates
Forward P/E14.18
Forward EPS30.29
Target Mean Price482.38
Dividend
Dividend Yield1.61%
Annual dividends6.87 USD
Ex-Div. DateDec. 4, 2026
Payout29.17%
5y avg Yield1.18%

DCF valuation

Model fair value for Elevance Health Inc. Common Stock (ELV)
Result
Sign in to run the valuation for ELV.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
21 analysts · consensus Buy · mean target 482.38 USD (low 406.00, high 523.00) · as of 12 Nov 2026
Low 406.00
Mean 482.38
High 523.00
Price 429.69
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Elevance Health Inc. Common Stock Logo Elevance Health Inc. Common Stock Analysis (ELV)

United States Health Care Official Website Stock

Is Elevance Health Inc. Common Stock a good investment? Elevance Health Inc. Common Stock (ELV) is currently trading at 429.69 USD. Market analysts have a consensus price target of 482.38 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 18.24. This valuation is generally in line with the broader market.

Earnings Schedule: Elevance Health Inc. Common Stock is expected to release its next earnings report on Jan. 27, 2027. The market consensus estimate for Forward EPS is 30.29.

For income investors, Elevance Health Inc. Common Stock pays a dividend yield of 1.61%. With a payout ratio of 29%, the dividend appears sustainable.

Investor FAQ

Does Elevance Health Inc. Common Stock pay a dividend?

Yes, it pays an annual dividend of 6.87 USD (1.61% yield).

What asset class is Elevance Health Inc. Common Stock?

Elevance Health Inc. Common Stock is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Jan. 27, 2027. The company currently has a trailing EPS of 23.55.

Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Exchange Ticker
A58.SG
LSE (United Kingdom) 0HG8.L
ASE (United States) ELV
NYQ (United States) ANTM
Trades
Dividend Yield
1.61%
5y avg 1.18%
Annual Dividends
6.87USD
Next Ex. Div Date
Dec. 4, 2026
Payout Ratio
29.17%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
5.91 USD
Sept. 27, 2027 (estimated) 1.9693
June 25, 2027 (estimated) 1.9693
March 25, 2027 (estimated) 1.9693
▸2026
6.88 USD
Dec. 18, 2026 1.7200
Sept. 25, 2026 1.7200
June 25, 2026 1.7200
March 25, 2026 1.7200
▸2025
6.84 USD
Dec. 19, 2025 1.7100
Sept. 25, 2025 1.7100
June 25, 2025 1.7100
March 25, 2025 1.7100
▸2024
6.52 USD
Dec. 20, 2024 1.6300
Sept. 25, 2024 1.6300
June 25, 2024 1.6300
March 22, 2024 1.6300
▸2023
5.92 USD
Dec. 21, 2023 1.4800
Sept. 22, 2023 1.4800
June 23, 2023 1.4800
March 24, 2023 1.4800
▸2022
5.12 USD
Dec. 21, 2022 1.2800
Sept. 23, 2022 1.2800
June 24, 2022 1.2800
March 25, 2022 1.2800
▸2021
4.52 USD
Dec. 21, 2021 1.1300
Sept. 24, 2021 1.1300
June 25, 2021 1.1300
March 25, 2021 1.1300
▸2020
3.80 USD
Dec. 22, 2020 0.9500
Sept. 25, 2020 0.9500
June 25, 2020 0.9500
March 27, 2020 0.9500
▸2019
3.20 USD
Dec. 20, 2019 0.8000
Sept. 25, 2019 0.8000
June 25, 2019 0.8000
March 29, 2019 0.8000
▸2018
3.00 USD
Dec. 21, 2018 0.7500
Sept. 25, 2018 0.7500
June 25, 2018 0.7500
March 23, 2018 0.7500
▸2017
2.70 USD
Dec. 21, 2017 0.7000
Sept. 25, 2017 0.7000
June 23, 2017 0.6500
March 24, 2017 0.6500
▸2016
2.60 USD
Dec. 21, 2016 0.6500
Sept. 26, 2016 0.6500
June 24, 2016 0.6500
March 25, 2016 0.6500
▸2015
2.50 USD
Dec. 21, 2015 0.6250
Sept. 25, 2015 0.6250
June 25, 2015 0.6250
March 25, 2015 0.6250
▸2014
1.75 USD
Dec. 22, 2014 0.4380
Sept. 25, 2014 0.4380
June 25, 2014 0.4380
March 25, 2014 0.4380
▸2013
1.50 USD
Dec. 23, 2013 0.3750
Sept. 25, 2013 0.3750
June 25, 2013 0.3750
March 25, 2013 0.3750
▸2012
1.15 USD
Dec. 21, 2012 0.2870
Sept. 25, 2012 0.2880
June 25, 2012 0.2880
March 23, 2012 0.2880
▸2011
1.00 USD
Dec. 23, 2011 0.2500
Sept. 23, 2011 0.2500
June 24, 2011 0.2500
March 25, 2011 0.2500
Upcoming Dividends
Name Payment Date Status Amount
Elevance Health Inc. Common Stock Dec 18, 2026 Upcoming 1.72 USD
Elevance Health Inc. Common Stock Sep 25, 2026 1.72 USD
Elevance Health Inc. Common Stock Jun 25, 2026 1.72 USD
Elevance Health Inc. Common Stock Mar 25, 2026 1.72 USD
Elevance Health Inc. Common Stock Dec 19, 2025 1.71 USD
Stock Splits
Split Date Split Ratio to 1
June 1, 2005 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion